Neurology
Found 6 results
Filters: Keyword is Atrophy  [Clear All Filters]
2020
Bagnato F, Gauthier SA, Laule C, Moore GRWayne, Bove R, Cai Z, Cohen-Adad J, Harrison DM, Klawiter EC, Morrow SA et al..  2020.  Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy.. J Neuroimaging. 30(3):251-266.
2018
Kuceyeski A, Monohan E, Morris E, Fujimoto K, Vargas W, Gauthier SA.  2018.  Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis.. Neuroimage Clin. 19:417-424.
Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, Matthews DC, Ganzer C, Osorio RS, Isaacson RS et al..  2018.  Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.. BMJ Open. 8(3):e019362.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT et al..  2018.  Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.. N Engl J Med. 379(9):846-855.
2015
Kuceyeski AF, Vargas W, Dayan M, Monohan E, Blackwell C, Raj A, Fujimoto K, Gauthier SA.  2015.  Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.. AJNR Am J Neuroradiol. 36(4):702-9.
2014
Mosconi L, Murray J, Tsui WH, Li Y, Spector N, Goldowsky A, Williams S, Osorio R, McHugh P, Glodzik L et al..  2014.  Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD.. Neurology. 82(9):752-60.